Default: Drug Safety

ISSN: 0114-5916

Journal Home

Journal Guideline

Drug Safety Q1 Unclaimed

Adis International Ltd United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Drug Safety is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 120. It has a price of 2990 €. It has an SJR impact factor of 1,148 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -


2990 €

Gold OA


Green OA

0 €

Non OA


Drug Safety


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

A Comparison of the Empirical Performance of Methods for a Risk Identification System

View more

A Cross-Country Comparison of Rivaroxaban Spontaneous Adverse Event Reports and Concomitant Medicine Use with the Potential to Increase the Risk of Harm

View more

A Retrospective Evaluation of a Data Mining Approach to Aid Finding New Adverse Drug Reaction Signals in the WHO International Database

View more

A Risk-Benefit Assessment of Anthracycline Antibiotics in Antineoplastic Therapy

View more

A Risk-Benefit Assessment of Corticosteroids in the Management of Croup

View more

A Risk-Benefit Assessment of Intra-Articular Corticosteroids in Rheumatic Disorders

View more

A Risk-Benefit Assessment of Levofloxacin in Respiratory, Skin and Skin Structure, and Urinary Tract Infections

View more

A Risk-Benefit Assessment of Tacrine in the Treatment of Alzheimer??s Disease

View more

Advances in the Pharmacological Treatment of Gastro-Oesophageal Cancer

View more

Adverse Drug Reaction Reporting in the UK

View more

Adverse Drug Reactions in Patients with Phaeochromocytoma

View more

Adverse Drug Reactions in the Paediatric Population in Denmark

View more

Adverse Effects of Drugs Used in the Management of Constipation and Diarrhoea

View more

Adverse Reactions Induced by NSAIDs and Antibacterials

View more

African Heat

View more

Allopurinol Hypersensitivity: A Systematic Review of All Published Cases, 1950-2012

View more

An Integrated Analysis of the Safety of Tofacitinib in Psoriatic Arthritis across Phase III and Long-Term Extension Studies with Comparison to Real-World Observational Data

View more

Antiretroviral Therapy in Pregnancy

View more

Aristolochic Acid Nephropathy: Epidemiology, Clinical Presentation, and Treatment

View more

Association Between Statin Use and Bell's Palsy: A Population-Based Study

View more

Author's Reply to Carracedo-Martinez E Comment on: "Prescribing of Rosiglitazone and Pioglitazone Following Safety Signals: Analysis of Trends in Dispensing Patterns in The Netherlands from 1998 to 2008"

View more

Authors' Reply to Ahmad SR: "Adverse Drug Reaction Reporting by Patients: An Overview of Fifty Countries"

View more

Authors' Reply to Harpaz et al. Comment on: "Zoo or Savannah? Choice of Training Ground for Evidence-Based Pharmacovigilance"

View more

Benefits and Risks of Pharmacotherapy for Narcolepsy

View more


No comments ... Be the first to comment!